Drug:
Reaction: MALIGNANT NEOPLASM PROGRESSION
20250101 - 20251231
No. 901 - 1000
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 901 | 24933640 |
US |
66 | 1 |
Malignant neoplasm progression, Adverse drug reaction, Blood pressure increased, Dysphonia, Gingival pain, Dyspnoea, |
||||
CABOZANTINIB, CABOZANTINIB, METOPROLOL TARTRATE, METOPROLOL, |
||||
| 902 | 24933644 |
MY |
1 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 903 | 24933649 |
CA |
77 | 1 |
Malignant neoplasm progression, |
||||
CABOZANTINIB, FUROSEMIDE, PREDNISONE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, LORAZEPAM, TAMSULOSIN HYDROCHLORIDE, DEXLANSOPRAZOLE, ADRENALINUM, ARGENTUM NITRICUM, BOS TAURUS PITUITARUM POSTERIUM, GLYCERINUM, GLYCYRRHIZA GLABRA, KALI CARBONICUM, LACTICUM ACIDUM, MAGNESIA SULPHURICA, NICCOLUM METALLICUM, PANCREATINUM, PHOSPHORICUM ACIDUM, SACCHARINUM, SACCHARUM LACTIS, SACCHARUM OFFICINALE, SARCOLACTICUM ACIDUM, SELENIUM METALLICUM, SYZYGIUM JAMBOLANUM, THYROIDINUM, ZINCUM METALLICUM, ACONITUM NAPELLUS, APIS MELLIFICA, ARNICA MONTANA, ARSENICUM ALBUM, BELLADONNA, BELLIS PERENNIS, BRYONIA ALBA, CALENDULA OFFICINALIS, CHAMOMILLA, CHERRY PLUM, CLEMATIS, COLOCYNTHIS, DULCAMARA, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, EUPATORIUM PERFOLIATUM, FERRUM PHOSPHORICUM, HAMAMELIS VIRGINIANA, HISTAMINUM, HYPERICUM PERFORATUM, IMPATIENS, MILLEFOLIUM, RHUS TOXICODENDRON, ROCK ROSE, STAR OF BETHLEHEM, SULPHUR, SYMPHYTUM OFFICINALE, VERATRUM ALBUM, ACONITUM NAPELLUS,APIS MELLIFICA,ARNICA MONTANA,ARSENICUM ALBUM,BELLADONNA,BELLIS PERENNIS,BRYONIA,CALENDULA OFFICINALIS,CHAMOMILLA,CHERRY PLUM,CLEMATIS VITALBA,COLOCYNTHIS,COMFREY,DULCAMARA LIGNOSA,ECHINACEA ANGUSTIFOLIA,ECHINACEA PURPUREA,EUPATORIUM PERFOLIATUM,FERRUM PHOSPHORICUM,HAMAMELIS VIRGINIANA,HISTAMINUM,HYPERICUM PERFORATUM,IMPATIENS GLANDULIFERA,LEDUM PALUSTRE,MENTHA PIPERITA,MILLEFOLIUM,ORNITHOGALUM UMBELLATUM,PLANTAGO MAJOR,RHUS TOXICODENDRON,ROCKROSE,SULPHUR,VERATRUM ALBUM,VERBASCUM THAPSUS, ALFALFA, ANTIMONIUM CRUDUM, AVENA SATIVA, BERBERIS VULGARIS, CAJUPUTUM, CARBO ANIMALIS, CARBO VEGETABILIS, CHELIDONIUM MAJUS, FEL TAURI, GENTIANA LUTEA, GLYCYRRHIZA GLABRA, ILLICIUM ANISATUM, INDOLUM, KALI CARBONICUM, LYCOPODIUM CLAVATUM, MAGNESIA PHOSPHORICA, NUX VOMICA, PANCREATINUM, PEPSINUM, RAPHANUS SATIVUS, RHAMNUS PURSHIANA, SKATOLUM, ALLIUM SATIVUM, AVENA SATIVA, CALCAREA CARBONICA, CALCAREA FLUORICA, CALCAREA PHOSPHORICA, CALCAREA SULPHURICA, CARBO VEGETABILIS, FERRUM IODATUM, HYPERICUM PERFORATUM, KALI PHOSPHORICUM, LACTICUM ACIDUM, MAGNESIA PHOSPHORICA, NATRUM MURIATICUM, NATRUM PHOSPHORICUM, PHOSPHORICUM ACIDUM, URTICA URENS, AVENA SATIVA, CHAMOMILLA, CHERRY PLUM, CLEMATIS VITALBA, COFFEA CRUDA, ENGLISH OAK, ESCHSCHOLTZIA CALIFORNICA, EUROPEAN HORNBEAM, FICUS CARICA, HUMULUS LUPULUS, IGNATIA AMARA, IMPATIENS GLANDULIFERA, KALI PHOSPHORICUM, KALI SILICATUM, MELISSA OFFICINALIS, PASSIFLORA INCARNATA, PHOSPHORICUM ACIDUM, PYRENEES STAR OF BETHLEHEM, ROCKROSE, SUS SCROFA PARASYMPATHETIC NERVE, PINEAL GLAND, SYMPATHETIC NERVE, VALERIANA OFFICINALIS, VERBENA OFFICINALIS, ZINCUM VALERIANICUM, ADRENALINUM, AETHUSA CYNAPIUM, AGNUS CASTUS, ALFALFA, ARGENTUM NITRICUM, AURUM METALLICUM, AVENA SATIVA, CERATOSTIGMA WILLMOTTIANUM FLOWER, CHERRY PLUM FLOWER, DAMIANA, EUROPEAN ASPEN FLOWER, EUROPEAN HORNBEAM FLOWER, GORSE FLOWER, HYPERICUM PERFORATUM, KALI PHOSPHORICUM, LYCOPODIUM CLAVATUM, MANDRAGORA OFFICINARUM, NATRUM MURIATICUM, PASSIFLORA INCARNATA, ROSA CANINA FLOWER, SEPIA, SWEET CHESTNUT FLOWER, THYROIDINUM, WILD MUSTARD FLOWER, BELLADONNA, BLATTA ORIENTALIS, COCCUS CACTI, CORALLIUM RUBRUM, CUPRUM METALLICUM, DROSERA ROTUNDIFOLIA, ECHINACEA ANGUSTIFOLIA, HEDERA HELIX, HYDRASTIS CANADENSIS, IPECACUANHA, KALI NITRICUM, LAC VACCINUM, LOBELIA INFLATA, PASSIFLORA INCARNATA, PERTUSSINUM, SAMBUCUS NIGRA, THYMUS SERPYLLUM, VALERIANA OFFICINALIS, BALSAMUM PERUVIANUM, BORAX, BRYONIA, CALCAREA ACETICA, COCCUS CACTI, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, EUCALYPTUS GLOBULUS, EUPHORBIUM OFFICINARUM, EUPHRASIA OFFICINALIS, HISTAMINUM HYDROCHLORICUM, IPECACUANHA, KALI BICHROMICUM, LUFFA OPERCULATA, MERCURIUS CYANATUS, MERCURIUS DULCIS, MERCURIUS SULPHURATUS RUBER, NATRUM ARSENICICUM, PANCREATINUM, SAMBUCUS NIGRA, SANGUINARINUM NITRICUM, SAPONARIA OFFICINALIS, ALLIUM CEPA, CALCAREA IODATA, CALCAREA SULPHURICA, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, EUPHORBIUM OFFICINARUM, HEPAR SULPHURIS CALCAREUM, HISTAMINUM HYDROCHLORICUM, HYDRASTIS CANADENSIS, KALI BICHROMICUM, KALI MURIATICUM, KALI SULPHURICUM, LAC DEFLORATUM, LUFFA OPERCULATA, MERCURIUS SULPHURATUS RUBER, PHOSPHORUS, PULSATILLA VULGARIS, SACCHARUM LACTIS, THUJA OCCIDENTALIS, ACONITUM NAPELLUS, ARSENICUM ALBUM, BAPTISIA TINCTORIA, BELLADONNA, BRYONIA, CHERRY PLUM, CLEMATIS VITALBA, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, EUCALYPTUS GLOBULUS, EUPATORIUM PERFOLIATUM, EUROPEAN OLIVE, FERRUM PHOSPHORICUM, GENTIANA LUTEA, IMPATIENS GLANDULIFERA, INFLUENZA A VIRUS, LACHESIS MUTUS, LUFFA OPERCULATA, ORNITHOGALUM UMBELLATUM, PHOSPHORUS, ROCKROSE, SARCOLACTICUM ACIDUM, VERATRUM ALBUM, YELLOW JASMINE, ARISTOLOCHIA MILHOMENS, ARNICA MONTANA, ARSENICUM ALBUM, BELLADONNA, BELLIS PERENNIS, BRYONIA, CALENDULA OFFICINALIS, CARBO VEGETABILIS, CHAMOMILLA, CHERRY PLUM FLOWER, CLEMATIS VITALBA FLOWER, ECHINACEA ANGUSTIFOLIA, HAMAMELIS VIRGINIANA, HEPAR SULPHURIS CALCAREUM, HYPERICUM PERFORATUM, IMPATIENS GLANDULIFERA FLOWER, LACHESIS MUTUS, MILLEFOLIUM, PYRENEES STAR OF BETHLEHEM, RHUS TOXICODENDRON, ROCKROSE FLOWER, RUTA GRAVEOLENS, SARCOLACTICUM ACIDUM, SULPHUR IODATUM, SYMPHYTUM OFFICINALE, VERATRUM ALBUM, ACONITUM NAPELLUS, APIS MELLIFICA, ARNICA MONTANA, ARSENICUM ALBUM, BELLADONNA, BELLIS PERENNIS, BRYONIA, CALENDULA, CHAMOMILLA, CHERRY PLUM, CLEMATIS VITALBA, COLOCYNTHIS, DULCAMARA LIGNOSA, ECHINACEA, EUPATORIUM, FERRUM PHOSPHORICUM, HAMAMELIS VIRGINIANA, HISTAMINUM, HYPERICUM PERFORATUM, IMPATIENS GLANDULIFERA, LEDUM PALUSTRE, MENTHA PIPERITA, MILLEFOLIUM, PLANTAGO MAJOR, PYRENEES STAR OF BETHLEHEM, RHUS TOXICODENDRON, ROCKROSE, SULFUR, COMFREY, VERATRUM ALBUM, VERBASCUM THAPSUS, ACETICUM ACIDUM, ADRENALINUM, AMERICAN GINSENG, ARNICA MONTANA, BALSAMUM PERUVIANUM, BOS TAURUS PITUITARUM POSTERIUM, CHERRY PLUM FLOWER, CHININUM ARSENICOSUM, CINCHONA OFFICINALIS, CLEMATIS VITALBA FLOWER, DAMIANA, EUROPEAN HORNBEAM FLOWER, EUROPEAN OLIVE FLOWER, GLYCYRRHIZA GLABRA, IMPATIENS GLANDULIFERA FLOWER, KALI PHOSPHORICUM, LYCOPODIUM CLAVATUM, MAGNESIA PHOSPHORICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, PYRENEES STAR OF BETHLEHEM, ROCKROSE FLOWER, SELENIUM METALLICUM, THYROIDINUM, PREGABALIN, BISOPROLOL FUMARATE, RIVAROXABAN, |
||||
| 904 | 24933650 |
US |
2 | |
Malignant neoplasm progression, Off label use, |
||||
CABOZANTINIB, |
||||
| 905 | 24933658 |
AT |
59 | 1 |
Malignant neoplasm progression, Off label use, |
||||
CABOZANTINIB, CABOZANTINIB, DENOSUMAB, SIMVASTATIN, HYDROMORPHONE HYDROCHLORIDE, INSULIN GLARGINE-YFGN, |
||||
| 906 | 24933662 |
US |
1 | |
Dehydration, Surgery, Malignant neoplasm progression, Thyroid disorder, Fatigue, Diarrhoea, Spleen disorder, Procedural pain, Flatulence, Feeding disorder, |
||||
CABOZANTINIB, |
||||
| 907 | 24933668 |
CZ |
66 | 2 |
Malignant neoplasm progression, |
||||
CABOZANTINIB, CABOZANTINIB, |
||||
| 908 | 24933681 |
US |
1 | |
Malignant neoplasm progression, Hepatic cancer metastatic, Gingival bleeding, Blood pressure increased, |
||||
CABOZANTINIB, |
||||
| 909 | 24933684 |
RO |
53 | 1 |
Metastases to bone, Malignant neoplasm progression, Drug ineffective, |
||||
CABOZANTINIB, |
||||
| 910 | 24933685 |
CZ |
71 | 2 |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 911 | 24933688 |
US |
58 | 1 |
Hypothyroidism, Malignant neoplasm progression, Burning sensation, Drug eruption, Palmar-plantar erythrodysaesthesia syndrome, Cancer pain, Limb mass, Myalgia, Back pain, |
||||
CABOZANTINIB, |
||||
| 912 | 24933705 |
CA |
1 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, CALCIUM, ERGOCALCIFEROL, LEVOTHYROXINE SODIUM, |
||||
| 913 | 24933713 |
US |
49 | |
Malignant neoplasm progression, Asthenia, Therapy partial responder, |
||||
CABOZANTINIB, CABOZANTINIB, |
||||
| 914 | 24933716 |
AU |
||
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 915 | 24933717 |
US |
68 | 1 |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 916 | 24933725 |
GB |
1 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 917 | 24933729 |
US |
2 | |
Malignant neoplasm progression, Illness, Adverse drug reaction, Diarrhoea, |
||||
CABOZANTINIB, CABOZANTINIB, |
||||
| 918 | 24933730 |
IN |
||
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 919 | 24933731 |
US |
1 | |
Malignant neoplasm progression, Abdominal discomfort, Diarrhoea, Fatigue, Nausea, |
||||
CABOZANTINIB, CABOZANTINIB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LEVOTHYROXINE, AMLODIPINE, LOSARTAN, CETIRIZINE HYDROCHLORIDE, OMEPRAZOLE MAGNESIUM, |
||||
| 920 | 24933733 |
US |
61 | 1 |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 921 | 24933734 |
AU |
70 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 922 | 24933735 |
US |
2 | |
Malignant neoplasm progression, Adverse drug reaction, Mental disorder, Depressed mood, |
||||
CABOZANTINIB, CABOZANTINIB, |
||||
| 923 | 24933737 |
BE |
57 | 1 |
Gastrointestinal stromal tumour, Malignant neoplasm progression, |
||||
CABOZANTINIB, IMATINIB, REGORAFENIB, |
||||
| 924 | 24933738 |
US |
1 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 925 | 24933739 |
MY |
56 | 2 |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 926 | 24933748 |
CH |
||
Malignant neoplasm progression, Off label use, |
||||
CABOZANTINIB, |
||||
| 927 | 24933749 |
US |
1 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 928 | 24933752 |
TH |
51 | 2 |
Malignant neoplasm progression, Therapeutic product effect decreased, |
||||
CABOZANTINIB, NIVOLUMAB, |
||||
| 929 | 24933753 |
US |
1 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 930 | 24933756 |
CA |
1 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, ROSUVASTATIN, MOMETASONE, |
||||
| 931 | 24933758 |
US |
74 | 1 |
Hypothyroidism, Malignant neoplasm progression, Hypoacusis, Somnolence, Epistaxis, Pain, Diarrhoea, Fatigue, Hypocalcaemia, Platelet count abnormal, Loss of personal independence in daily activities, Oedema peripheral, Cough, |
||||
CABOZANTINIB, CABOZANTINIB, DENOSUMAB, |
||||
| 932 | 24933761 |
US |
65 | 1 |
Hypokalaemia, Biliary obstruction, Renal failure, Oedema mucosal, Malignant neoplasm progression, Metastases to skin, Metastases to pancreas, Rash pruritic, Diarrhoea, Acne, Thyroiditis, Intrapulmonary lymphadenopathy, Nodule, Faeces pale, Haemoptysis, Arthralgia, |
||||
CABOZANTINIB, NIVOLUMAB, EVEROLIMUS, EVEROLIMUS TABLETS, LENVATINIB, LENVATINIB, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ERGOCALCIFEROL, CLINDAMYCIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, ESOMEPRAZOLE MAGNESIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LOSARTAN POTASSIUM, MELATONIN, NIACIN, ROSUVASTATIN, KENALOG, VITAMIN A, PANTOPRAZOLE SODIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, POLYETHYLENE GLYCOL, ONDANSETRON HYDROCHLORIDE, VITAMIN E, CREAM, DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, ROSUVASTATIN CALCIUM, |
||||
| 933 | 24933765 |
US |
2 | |
Malignant neoplasm progression, Drug ineffective, |
||||
CABOZANTINIB, |
||||
| 934 | 24933769 |
US |
68 | 1 |
Malignant neoplasm progression, Alanine aminotransferase abnormal, Aspartate aminotransferase abnormal, Blood alkaline phosphatase abnormal, Neutrophil count decreased, Erythema, Hypertension, Fatigue, Decreased appetite, Diarrhoea, Weight decreased, Off label use, |
||||
CABOZANTINIB, CABOZANTINIB, TELOTRISTAT ETHYL, TELOTRISTAT ETHYL, TELOTRISTAT ETHYL, WARFARIN, FERROUS SULFATE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, TORSEMIDE, SPIRONOLACTONE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, DULOXETINE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, |
||||
| 935 | 24933771 |
US |
2 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 936 | 24933772 |
US |
70 | 1 |
Malignant neoplasm progression, Drug hypersensitivity, Surgery, Inappropriate schedule of product administration, Product dose omission issue, |
||||
CABOZANTINIB, LEVOTHYROXINE SODIUM, ERGOCALCIFEROL, |
||||
| 937 | 24933774 |
US |
2 | |
Malignant neoplasm progression, Arthralgia, |
||||
CABOZANTINIB, CABOZANTINIB, |
||||
| 938 | 24933775 |
US |
1 | |
Malignant neoplasm progression, Taste disorder, Gingival bleeding, Decreased appetite, |
||||
CABOZANTINIB, APIXABAN, |
||||
| 939 | 24933777 |
CO |
81 | 1 |
Myocardial infarction, Cardiac failure, Pulmonary embolism, Malignant neoplasm progression, Skin lesion, Gingival pain, Diarrhoea, Asthenia, Decreased appetite, |
||||
CABOZANTINIB, CABOZANTINIB, CABOZANTINIB, LEVOTHYROXINE, CARVEDILOL, RIVAROXABAN, ALLOPURINOL, AMLODIPINE, |
||||
| 940 | 24933780 |
US |
2 | |
Malignant neoplasm progression, Nausea, |
||||
CABOZANTINIB, |
||||
| 941 | 24933782 |
CA |
64 | 1 |
Malignant neoplasm progression, |
||||
CABOZANTINIB, LEVOTHYROXINE, TELMISARTAN, |
||||
| 942 | 24933785 |
CA |
1 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, BISOPROLOL FUMARATE, SACUBITRIL AND VALSARTAN, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, AMLODIPINE, SPIRONOLACTONE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, RIVAROXABAN, PROCHLORPERAZINE, UREA, CREAM, |
||||
| 943 | 24933814 |
PL |
1 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 944 | 24933824 |
TH |
68 | 1 |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 945 | 24933826 |
PL |
2 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 946 | 24933835 |
MY |
83 | 1 |
Diarrhoea, Fatigue, Asthenia, Malignant neoplasm progression, Drug ineffective, |
||||
CABOZANTINIB, |
||||
| 947 | 24933836 |
TH |
37 | 2 |
Death, Dyspnoea, Malignant neoplasm progression, Wrong technique in product usage process, |
||||
CABOZANTINIB, CABOZANTINIB, |
||||
| 948 | 24933837 |
BE |
68 | 1 |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 949 | 24933840 |
CA |
1 | |
Malignant neoplasm progression, Therapeutic product ineffective, |
||||
CABOZANTINIB, METOPROLOL TARTRATE, METOPROLOL, PERINDOPRIL ERBUMINE, INDOMETHACIN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, PREGABALIN, |
||||
| 950 | 24933845 |
CA |
66 | 1 |
Palmar-plantar erythrodysaesthesia syndrome, Malignant neoplasm progression, |
||||
CABOZANTINIB, CABOZANTINIB, NIVOLUMAB, |
||||
| 951 | 24933849 |
US |
1 | |
Malignant neoplasm progression, Sleep disorder, Stress, Fatigue, |
||||
CABOZANTINIB, ALBUTEROL SULFATE, ALBUTEROL, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LEVOTHYROXINE SODIUM, |
||||
| 952 | 24933855 |
US |
1 | |
Malignant neoplasm progression, Arthritis, Skin ulcer, |
||||
CABOZANTINIB, |
||||
| 953 | 24933856 |
US |
2 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, LEVOTHYROXINE, |
||||
| 954 | 24933857 |
CO |
52 | 1 |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 955 | 24933859 |
US |
1 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 956 | 24933860 |
US |
20 | 1 |
Asthenia, Spinal decompression, Back pain, Malignant neoplasm progression, Metastases to meninges, Arthralgia, Palmar-plantar erythrodysaesthesia syndrome, Off label use, |
||||
CABOZANTINIB, CABOZANTINIB, CABOZANTINIB, LENVATINIB, EVEROLIMUS, EVEROLIMUS TABLETS, ONDANSETRON HYDROCHLORIDE, |
||||
| 957 | 24933864 |
CO |
59 | 2 |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 958 | 24933865 |
CO |
50 | 1 |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 959 | 24933866 |
CO |
68 | 1 |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 960 | 24933867 |
US |
75 | 1 |
Malignant neoplasm progression, Thinking abnormal, Disturbance in attention, Impaired healing, Taste disorder, Diarrhoea, Decreased appetite, Weight decreased, Drug ineffective, Skin infection, Inappropriate schedule of product administration, |
||||
CABOZANTINIB, CABOZANTINIB, CABOZANTINIB, CABOZANTINIB, LENVATINIB, |
||||
| 961 | 24933869 |
CA |
1 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DEXLANSOPRAZOLE, |
||||
| 962 | 24933871 |
CO |
61 | 2 |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 963 | 24933872 |
US |
2 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, CALCIUM, AMLODIPINE BESYLATE, LEVOTHYROXINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 964 | 24933882 |
US |
2 | |
Malignant neoplasm progression, Hyperkeratosis, Glycosylated haemoglobin increased, Blood magnesium decreased, Blood glucose increased, Fatigue, Diarrhoea, Pain in extremity, |
||||
CABOZANTINIB, CABOZANTINIB, EZETIMIBE, PANTOPRAZOLE, ROSUVASTATIN, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, FLUCONAZOLE, ALBUTEROL SULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, GABAPENTIN, LEVOTHYROXINE, LISINOPRIL, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, INSULIN ASPART, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, INSULIN DEGLUDEC, VITAMIN C, ERGOCALCIFEROL, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 965 | 24933884 |
US |
50 | 1 |
Malignant neoplasm progression, |
||||
CABOZANTINIB, NIVOLUMAB, LEVOTHYROXINE, ALBUTEROL SULFATE, ALBUTEROL, AMLODIPINE, GABAPENTIN, LOSARTAN, POLYETHYLENE GLYCOL 3350, THIAMINE HYDROCHLORIDE, |
||||
| 966 | 24933888 |
US |
1 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 967 | 24933890 |
US |
71 | 1 |
Malignant neoplasm progression, |
||||
CABOZANTINIB, CABOZANTINIB, CALCIUM, FISH OIL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 968 | 24933892 |
ES |
60 | 2 |
Malignant neoplasm progression, Hypothyroidism, Metastases to central nervous system, Asthenia, Palmar-plantar erythrodysaesthesia syndrome, Anaemia, Decreased appetite, Nausea, |
||||
CABOZANTINIB, CABOZANTINIB, CABOZANTINIB, CABOZANTINIB, LEVOTHYROXINE, LEVOTHYROXINE, DENOSUMAB, |
||||
| 969 | 24933895 |
CO |
70 | 2 |
Malignant neoplasm progression, Drug ineffective, |
||||
CABOZANTINIB, |
||||
| 970 | 24933899 |
CA |
2 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, LORAZEPAM, BUPROPION HYDROCHLORIDE, BUPROPION, LEVOTHYROXINE SODIUM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, APIXABAN, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, DIMENHYDRINATE, SENNOSIDES, SENNA LEAF, SENNA, SENNOSIDES 8.6 MG TABLETS, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, FUROSEMIDE, SPIRONOLACTONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, VITAMIN C, ERGOCALCIFEROL, |
||||
| 971 | 24933900 |
US |
1 | |
Malignant neoplasm progression, Drug ineffective, |
||||
CABOZANTINIB, |
||||
| 972 | 24933902 |
CO |
60 | 1 |
Malignant neoplasm progression, Drug ineffective, |
||||
CABOZANTINIB, |
||||
| 973 | 24933905 |
US |
2 | |
Malignant neoplasm progression, Skin ulcer, Stomatitis, Decreased appetite, Diarrhoea, Off label use, |
||||
CABOZANTINIB, CABOZANTINIB, |
||||
| 974 | 24933917 |
MY |
47 | 1 |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 975 | 24933925 |
CO |
55 | 2 |
Malignant neoplasm progression, Drug ineffective, |
||||
CABOZANTINIB, |
||||
| 976 | 24933934 |
US |
61 | 1 |
Malignant neoplasm progression, Drug ineffective, |
||||
CABOZANTINIB, CABOZANTINIB, AMLODIPINE BESYLATE, LEVOTHYROXINE, MIRTAZAPINE, OLANZAPINE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, OXYCODONE, PROCHLORPERAZINE, GABAPENTIN, MAGNESIUM OXIDE, |
||||
| 977 | 24933937 |
US |
45 | 2 |
Malignant neoplasm progression, Rash, Pain in extremity, Ageusia, Skin exfoliation, Off label use, |
||||
CABOZANTINIB, ENCORAFENIB, LEVOTHYROXINE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, BINIMETINIB, LOSARTAN, |
||||
| 978 | 24933940 |
US |
1 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 979 | 24933941 |
US |
1 | |
Malignant neoplasm progression, Adverse drug reaction, |
||||
CABOZANTINIB, CABOZANTINIB, CABOZANTINIB, NIVOLUMAB, NIVOLUMAB, NIVOLUMAB, |
||||
| 980 | 24933942 |
US |
2 | |
Malignant neoplasm progression, Drug ineffective, |
||||
CABOZANTINIB, CABOZANTINIB, PROCHLORPERAZINE MALEATE, CINACALCET, CINACALCET HYDROCHLORIDE, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, ACETAMINOPHEN, ASPRIN, CAFFEINE, ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE, ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE, ACETAMINOPHEN, ASPIRIN (NSAID), AND CAFFEINE, ACETAMINOPHEN, ASPIRIN, AND CAFFEINE, ACETAMINOPHEN, CAFFEINE, FAMOTIDINE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LEVOTHYROXINE, LISINOPRIL, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ERGOCALCIFEROL, OXYCODONE, |
||||
| 981 | 24933963 |
AU |
||
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 982 | 24933965 |
AT |
1 | |
Diarrhoea, Palmar-plantar erythrodysaesthesia syndrome, Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 983 | 24933969 |
AU |
||
Malignant neoplasm progression, Off label use, |
||||
CABOZANTINIB, CABOZANTINIB, |
||||
| 984 | 24933972 |
US |
2 | |
Malignant neoplasm progression, Blister, |
||||
CABOZANTINIB, CABOZANTINIB, |
||||
| 985 | 24933975 |
CA |
1 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, LEVOTHYROXINE SODIUM, AMLODIPINE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, BISOPROLOL FUMARATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, RANITIDINE, |
||||
| 986 | 24933984 |
US |
1 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CALCIUM, DICLOFENAC, DICLOFENAC SODIUM, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, GABAPENTIN, HYDROCHLOROTHIAZIDE, LISINOPRIL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METOPROLOL TARTRATE, METOPROLOL, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ROSUVASTATIN, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, ERGOCALCIFEROL, |
||||
| 987 | 24933987 |
US |
1 | |
Malignant neoplasm progression, Nausea, |
||||
CABOZANTINIB, |
||||
| 988 | 24933989 |
CA |
1 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, AMLODIPINE, PANTOPRAZOLE, MAGNESIUM, PEMBROLIZUMAB, AXITINIB, |
||||
| 989 | 24933992 |
US |
1 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 990 | 24933997 |
CA |
60 | 2 |
Malignant neoplasm progression, |
||||
CABOZANTINIB, LOSARTAN, LEVOTHYROXINE, AXITINIB, ERGOCALCIFEROL, |
||||
| 991 | 24933999 |
DE |
64 | 1 |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 992 | 24934001 |
US |
1 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, CABOZANTINIB, NIVOLUMAB, AMLODIPINE BESYLATE, CEPHALEXIN, EPLERENONE, IRON, LEVOTHYROXINE, LOSARTAN POTASSIUM, LOSARTAN, TAMSULOSIN HYDROCHLORIDE, ERGOCALCIFEROL, ERGOCALCIFEROL, |
||||
| 993 | 24934011 |
AU |
36 | 1 |
Malignant neoplasm oligoprogression, Malignant neoplasm progression, Therapeutic product effect incomplete, |
||||
CABOZANTINIB, CABOZANTINIB, CABOZANTINIB, NIVOLUMAB, |
||||
| 994 | 24934016 |
CA |
1 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 995 | 24934018 |
US |
73 | 2 |
Malignant neoplasm progression, Diarrhoea, Off label use, |
||||
CABOZANTINIB, CABOZANTINIB, |
||||
| 996 | 24934020 |
US |
1 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
| 997 | 24934027 |
US |
1 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, AXITINIB, |
||||
| 998 | 24934037 |
US |
1 | |
Malignant neoplasm progression, Drug ineffective, |
||||
CABOZANTINIB, |
||||
| 999 | 24934045 |
US |
57 | 1 |
Malignant neoplasm progression, Radiotherapy, Pruritus, Nausea, Asthenia, Weight decreased, Tremor, Salivary gland mass, Cancer pain, Neurological symptom, |
||||
CABOZANTINIB, CABOZANTINIB, CABOZANTINIB, AMLODIPINE BESYLATE, CETIRIZINE HYDROCHLORIDE, ERGOCALCIFEROL, HYDROXYZINE PAMOATE, LEVOTHYROXINE, ALBUTEROL SULFATE, OMEPRAZOLE MAGNESIUM, |
||||
| 1000 | 24934052 |
US |
1 | |
Malignant neoplasm progression, |
||||
CABOZANTINIB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28